Oral Rotavirus Vaccine

If infants and young children contract rotavirus, it can lead to severe gastroenteritis, accompanied by acute vomiting, diarrhea, and high fever. Therefore, it is advisable for infants and young children to receive the oral rotavirus vaccine after birth to prevent rotavirus infection.

Oral Rotavirus Vaccines:

Pentavalent Rotavirus Vaccine MSD
Three doses cover the five most common serotypes: G1, G2, G3, G4, and G9. In large clinical trials, RotaTeq demonstrated 98% protection against severe rotavirus gastroenteritis (fever, vomiting, diarrhea, and behavioral changes) and 74% protection against rotavirus gastroenteritis of any severity (stomach and intestinal inflammation). Infants who received the RotaTeq vaccine also had a 94% reduced likelihood of visiting the emergency room and a 96% reduced likelihood of hospitalization in the first two years after vaccination.

First dose: 6-12 weeks
Second dose: 10-28 weeks
Third dose: 14-32 weeks

Monovalent Rotavirus Vaccine GSK
Two doses cover rotavirus serotypes G1, G3, G4, and G9. Two clinical trials found that Rotarix provided 85% to 96% protection against severe rotavirus gastroenteritis. One study found that Rotarix was 96% effective in reducing hospitalization rates over two rotavirus seasons.

First dose: 6 to 20 weeks
Second dose: Before 24 weeks

Brochure Download